Showing results (61-70 of 216) with videos related to
Sort By:
Pageof 22
JNCI Cancer Spectrum|June 18, 2019
Consequences of Performing Parallel Dose Finding Trials in Heterogeneous Groups of PatientsBethany Jablonski Horton, John O'Quigley, Mark R ConawayClinical Trials (London, England)|October 3, 2013
Performance of two-stage continual reassessment method relative to an optimal benchmarkNolan A Wages, Mark R Conaway, John O'QuigleyStatistics in Medicine|July 27, 2012
Penalized likelihood estimation for semiparametric mixed models, with application to alcohol treatment researchJinsong Chen, Lei Liu, Bankole A Johnson, et al.Biostatistics (Oxford, England)|March 6, 2010
Dynamic calibration of pharmacokinetic parameters in dose-finding studiesJohn O'Quigley, Michael D Hughes, Terry Fenton, et al.Frontiers in Psychiatry|November 29, 2012
Obtaining the optimal dose in alcohol dependence studiesNolan A Wages, Lei Liu, John O'Quigley, et al.Pharmaceutical Statistics|November 7, 2019
Coherence principles in interval-based dose findingNolan A Wages, Alexia Iasonos, John O'Quigley, et al.Contemporary Clinical Trials|September 27, 2015
Two-group time-to-event continual reassessment method using likelihood estimationAmber Salter, John O'Quigley, Gary R Cutter, et al.Cancer Discovery|June 3, 2024
Optimus-Era Dose Finding for Rare CancersYonina R Murciano-Goroff, Sean M Devlin, Alexia Iasonos, et al.Thrombosis Research|April 29, 2018
Predictive factors of fatal bleeding in acute promyelocytic leukemiaSimon Mantha, Martin S Tallman, Sean M Devlin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2017
Dose Transition Pathways: The Missing Link Between Complex Dose-Finding Designs and Simple Decision-MakingChristina Yap, Lucinda J Billingham, Ying Kuen Cheung, et al.Pageof 22